PHIBRO ANIMAL HEALTH CORP (PAHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue TTM

0 600M 1.2B 1.8B Q4 '16: 751.5M Q1 '17: 752.4M Q2 '17: 752.2M Q3 '17: 758.6M Q4 '17: 764.3M Q1 '18: 769.7M Q2 '18: 784M Q3 '18: 803M Q4 '18: 820M Q1 '19: 826.7M Q2 '19: 839.1M Q3 '19: 835.9M Q4 '19: 828M Q1 '20: 817.6M Q2 '20: 813.4M Q3 '20: 818.4M Q4 '20: 800.4M Q1 '21: 805.8M Q2 '21: 798M Q3 '21: 799M Q4 '21: 833.4M Q1 '22: 852.8M Q2 '22: 879.4M Q3 '22: 907.3M Q4 '22: 942.3M Q1 '23: 960.1M Q2 '23: 972.1M Q3 '23: 978.1M Q4 '23: 977.9M Q1 '24: 976.7M Q2 '24: 982M Q3 '24: 999.6M Q4 '24: 1B Q1 '25: 1B Q2 '25: 1.1B Q3 '25: 1.2B Q4 '25: 1.3B Q1 '26: 1.4B Q2 '26: 1.5B Q3 '26: 1.5B Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Gross Profit TTM

0 200M 400M 600M Q4 '16: 239M Q1 '17: 240.8M Q2 '17: 242.9M Q3 '17: 244.7M Q4 '17: 248.2M Q1 '18: 250.6M Q2 '18: 254M Q3 '18: 262.5M Q4 '18: 266.9M Q1 '19: 269.3M Q2 '19: 271M Q3 '19: 266.8M Q4 '19: 264.6M Q1 '20: 256.5M Q2 '20: 256.9M Q3 '20: 261.6M Q4 '20: 256.9M Q1 '21: 263.3M Q2 '21: 262.5M Q3 '21: 262.1M Q4 '21: 271.4M Q1 '22: 271.9M Q2 '22: 274.3M Q3 '22: 276.8M Q4 '22: 285.4M Q1 '23: 289.4M Q2 '23: 296.1M Q3 '23: 300M Q4 '23: 298.2M Q1 '24: 297.3M Q2 '24: 298.5M Q3 '24: 302.6M Q4 '24: 313.1M Q1 '25: 328.9M Q2 '25: 352.1M Q3 '25: 377.1M Q4 '25: 399.9M Q1 '26: 436.2M Q2 '26: 467M Q3 '26: 488.1M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Operating Income TTM

0 70M 140M 210M Q4 '16: 85.7M Q1 '17: 85.7M Q2 '17: 85.7M Q3 '17: 94.5M Q4 '17: 97.9M Q1 '18: 98.5M Q2 '18: 99.8M Q3 '18: 96.3M Q4 '18: 98.9M Q1 '19: 99.4M Q2 '19: 101.2M Q3 '19: 97.2M Q4 '19: 83.2M Q1 '20: 70.5M Q2 '20: 64.4M Q3 '20: 63.2M Q4 '20: 69.2M Q1 '21: 74.7M Q2 '21: 75M Q3 '21: 73.8M Q4 '21: 74.9M Q1 '22: 73.8M Q2 '22: 76.2M Q3 '22: 75.3M Q4 '22: 79M Q1 '23: 78.1M Q2 '23: 71.6M Q3 '23: 71M Q4 '23: 71.8M Q1 '24: 57.4M Q2 '24: 57.3M Q3 '24: 58.7M Q4 '24: 53.3M Q1 '25: 71.7M Q2 '25: 81.6M Q3 '25: 95.2M Q4 '25: 110.5M Q1 '26: 144M Q2 '26: 168.8M Q3 '26: 180M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Net Income TTM

0 35M 70M 105M Q4 '16: 82.7M Q1 '17: 76.2M Q2 '17: 59.4M Q3 '17: 64.5M Q4 '17: 64.6M Q1 '18: 68.3M Q2 '18: 61.9M Q3 '18: 58.1M Q4 '18: 64.9M Q1 '19: 65.3M Q2 '19: 73M Q3 '19: 68M Q4 '19: 54.7M Q1 '20: 40.9M Q2 '20: 38.1M Q3 '20: 36.7M Q4 '20: 33.6M Q1 '21: 43.3M Q2 '21: 44.2M Q3 '21: 42.9M Q4 '21: 54.4M Q1 '22: 48.6M Q2 '22: 53.3M Q3 '22: 58.8M Q4 '22: 49.2M Q1 '23: 46.5M Q2 '23: 36.2M Q3 '23: 28.6M Q4 '23: 32.6M Q1 '24: 20.7M Q2 '24: 14.8M Q3 '24: 13.2M Q4 '24: 2.4M Q1 '25: 17.4M Q2 '25: 19.3M Q3 '25: 31.8M Q4 '25: 48.3M Q1 '26: 67.8M Q2 '26: 92.1M Q3 '26: 95.2M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Cost of Revenue TTM

0 350M 700M 1.1B Q4 '18: 553.1M Q1 '19: 557.4M Q2 '19: 568M Q3 '19: 569.1M Q4 '19: 563.4M Q1 '20: 561.1M Q2 '20: 556.4M Q3 '20: 556.7M Q4 '20: 543.5M Q1 '21: 542.5M Q2 '21: 535.5M Q3 '21: 536.8M Q4 '21: 562M Q1 '22: 580.9M Q2 '22: 605M Q3 '22: 630.5M Q4 '22: 656.9M Q1 '23: 670.7M Q2 '23: 676M Q3 '23: 678.1M Q4 '23: 679.7M Q1 '24: 679.4M Q2 '24: 683.5M Q3 '24: 697M Q4 '24: 704.6M Q1 '25: 717.9M Q2 '25: 754M Q3 '25: 813.6M Q4 '25: 896.3M Q1 '26: 963.4M Q2 '26: 997.3M Q3 '26: 1B Q3 '19 Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Operating Cash Flow TTM

-40M 0 40M 80M 120M Q4 '16: 37.2M Q1 '17: 61.1M Q2 '17: 79.3M Q3 '17: 111.4M Q4 '17: 98.4M Q1 '18: 81.7M Q2 '18: 87.7M Q3 '18: 73.5M Q4 '18: 70M Q1 '19: 66.5M Q2 '19: 49.6M Q3 '19: 42.4M Q4 '19: 47.2M Q1 '20: 42.3M Q2 '20: 59.1M Q3 '20: 70.3M Q4 '20: 59.3M Q1 '21: 64.6M Q2 '21: 59.4M Q3 '21: 49.1M Q4 '21: 48.3M Q1 '22: 50.4M Q2 '22: 43.6M Q3 '22: 33.1M Q4 '22: 31.6M Q1 '23: 17.1M Q2 '23: -5.5M Q3 '23: -5.4M Q4 '23: 13.3M Q1 '24: 40.2M Q2 '24: 74.3M Q3 '24: 79.4M Q4 '24: 87.6M Q1 '25: 84M Q2 '25: 55.5M Q3 '25: 87.3M Q4 '25: 80.1M Q1 '26: 76.8M Q2 '26: 93.1M Q3 '26: 66.1M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Free Cash Flow TTM

-70M -35M 0 35M 70M 105M Q4 '16: 866K Q1 '17: 26.9M Q2 '17: 50.1M Q3 '17: 88.3M Q4 '17: 77.5M Q1 '18: 61.8M Q2 '18: 68.6M Q3 '18: 55M Q4 '18: 51.5M Q1 '19: 46.9M Q2 '19: 27.7M Q3 '19: 17.1M Q4 '19: 17.3M Q1 '20: 10.8M Q2 '20: 25.2M Q3 '20: 36.3M Q4 '20: 25.3M Q1 '21: 30.8M Q2 '21: 26.8M Q3 '21: 16.8M Q4 '21: 19M Q1 '22: 21.1M Q2 '22: 13.9M Q3 '22: 897K Q4 '22: -5.4M Q1 '23: -35.6M Q2 '23: -60.4M Q3 '23: -58.1M Q4 '23: -38.5M Q1 '24: 4.1M Q2 '24: 37M Q3 '24: 40.3M Q4 '24: 46.4M Q1 '25: 40.7M Q2 '25: 15.3M Q3 '25: 49.1M Q4 '25: 41.8M Q1 '26: 34.3M Q2 '26: 47.3M Q3 '26: 12.8M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q3 '13: 30.5M Q1 '14: 30.5K Q2 '14: 30.5M Q3 '14: 30.7M Q1 '15: 39.6M Q2 '15: 39.8M Q3 '15: 39.9M Q1 '16: 40K Q2 '16: 40K Q3 '16: 40M Q1 '17: 39.9M Q2 '17: 40M Q3 '17: 40.1K Q1 '18: 40.3K Q2 '18: 40.4K Q3 '18: 40.4K Q1 '19: 40.6M Q2 '19: 40.5M Q3 '19: 40.5M Q1 '20: 40.5M Q2 '20: 40.5M Q3 '20: 40.5M Q1 '21: 40.5M Q2 '21: 40.5M Q3 '21: 40.5M Q1 '22: 40.5M Q2 '22: 40.5M Q3 '22: 40.5M Q1 '23: 40.5M Q2 '23: 40.5M Q3 '23: 40.5M Q1 '24: 40.5M Q2 '24: 40.5M Q3 '24: 40.5M Q1 '25: 40.6M Q2 '25: 40.7M Q3 '25: 40.7M Q1 '26: 40.9M Q2 '26: 41M Q3 '26: 41M Q1 '15 Q3 '16 Q2 '18 Q1 '20 Q3 '21 Q2 '23 Q1 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.80 1.60 2.40 Q4 '13: 0.83 Q1 '15: 0.30 Q2 '15: 0.58 Q3 '15: 0.79 Q4 '15: 1.52 Q2 '17: 1.49 Q3 '19: 1.68 Q4 '19: 1.35 Q1 '20: 1.01 Q2 '20: 0.94 Q3 '20: 0.90 Q4 '20: 0.82 Q1 '21: 1.06 Q2 '21: 1.09 Q3 '21: 1.06 Q4 '21: 1.34 Q1 '22: 1.20 Q2 '22: 1.31 Q3 '22: 1.45 Q4 '22: 1.21 Q1 '23: 1.15 Q2 '23: 0.90 Q3 '23: 0.71 Q4 '23: 0.82 Q1 '24: 0.52 Q2 '24: 0.37 Q3 '24: 0.33 Q4 '24: 0.06 Q1 '25: 0.43 Q2 '25: 0.48 Q3 '25: 0.78 Q4 '25: 1.19 Q1 '26: 1.67 Q2 '26: 2.26 Q3 '26: 2.34 Q4 '15 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.